UBS O'Connor’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,640
| Closed | -$88.4K | – | 356 |
|
|
2025
Q1 | $88.4K | Sell |
23,640
-75,275
| -76% | -$282K | ﹤0.01% | 227 |
|
|
2024
Q4 | $1M | Buy |
98,915
+19,170
| +24% | +$194K | 0.03% | 220 |
|
|
2024
Q3 | $993K | Buy |
79,745
+6,252
| +9% | +$77.8K | 0.02% | 273 |
|
|
2024
Q2 | $957K | Buy |
73,493
+25,338
| +53% | +$330K | 0.03% | 298 |
|
|
2024
Q1 | $1.09M | Sell |
48,155
-5,333
| -10% | -$121K | 0.03% | 263 |
|
|
2023
Q4 | $694K | Sell |
53,488
-4,959
| -8% | -$64.3K | 0.02% | 307 |
|
|
2023
Q3 | $1.17M | Buy |
58,447
+18,000
| +45% | +$362K | 0.02% | 307 |
|
|
2023
Q2 | $1.09M | Buy |
40,447
+860
| +2% | +$23.1K | 0.02% | 369 |
|
|
2023
Q1 | $2.31M | Buy |
+39,587
| New | +$2.31M | 0.05% | 290 |
|
|
2022
Q4 | – | Sell |
-18,081
| Closed | -$1.48M | – | 168 |
|
|
2022
Q3 | $1.48M | Buy |
18,081
+2,908
| +19% | +$238K | 0.02% | 685 |
|
|
2022
Q2 | $1.03M | Buy |
+15,173
| New | +$1.03M | 0.01% | 749 |
|
|
2015
Q4 | – | Sell |
-2,000
| Closed | -$316K | – | 452 |
|
|
2015
Q3 | $316K | Buy |
+2,000
| New | +$316K | 0.01% | 427 |
|
|
2015
Q2 | – | Sell |
-1,667
| Closed | -$765K | – | 789 |
|
|
2015
Q1 | $765K | Buy |
+1,667
| New | +$765K | 0.02% | 438 |
|